Chronotherapy for Hypertension

N. P. Bowles, S. S. Thosar, M. X. Herzig, Steven Shea

Research output: Contribution to journalReview article

7 Citations (Scopus)

Abstract

Purpose of Review: Given the emerging knowledge that circadian rhythmicity exists in every cell and all organ systems, there is increasing interest in the possible benefits of chronotherapy for many diseases. There is a well-documented 24-h pattern of blood pressure with a morning surge that may contribute to the observed morning increase in adverse cardiovascular events. Historically, antihypertensive therapy involves morning doses, usually aimed at reducing daytime blood pressure surges, but an absence of nocturnal dipping blood pressure is also associated with increased cardiovascular risk. Recent Findings: To more effectively reduce nocturnal blood pressure and still counteract the morning surge in blood pressure, a number of studies have examined moving one or more antihypertensives from morning to bedtime dosing. More recently, such studies of chronotherapy have studied comorbid populations including obstructive sleep apnea, chronic kidney disease, or diabetes. Summary: Here, we summarize major findings from recent research in this area (2013–2017). In general, nighttime administration of antihypertensives improved overall 24-h blood pressure profiles regardless of disease comorbidity. However, inconsistencies between studies suggest a need for more prospective randomized controlled trials with sufficient statistical power. In addition, experimental studies to ascertain mechanisms by which chronotherapy is beneficial could aid drug design and guidelines for timed administration.

Original languageEnglish (US)
Article number97
JournalCurrent Hypertension Reports
Volume20
Issue number11
DOIs
StatePublished - Nov 1 2018

Fingerprint

Chronotherapy
Blood Pressure
Hypertension
Antihypertensive Agents
Drug Design
Obstructive Sleep Apnea
Periodicity
Chronic Renal Insufficiency
Comorbidity
Randomized Controlled Trials
Guidelines
Research
Population

Keywords

  • Blood pressure
  • Chronotherapy
  • Circadian rhythms
  • Hypertension
  • Non-dipping
  • Sleep

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Chronotherapy for Hypertension. / Bowles, N. P.; Thosar, S. S.; Herzig, M. X.; Shea, Steven.

In: Current Hypertension Reports, Vol. 20, No. 11, 97, 01.11.2018.

Research output: Contribution to journalReview article

Bowles, N. P. ; Thosar, S. S. ; Herzig, M. X. ; Shea, Steven. / Chronotherapy for Hypertension. In: Current Hypertension Reports. 2018 ; Vol. 20, No. 11.
@article{4805c4a423d14ff9966b5a4b1a386109,
title = "Chronotherapy for Hypertension",
abstract = "Purpose of Review: Given the emerging knowledge that circadian rhythmicity exists in every cell and all organ systems, there is increasing interest in the possible benefits of chronotherapy for many diseases. There is a well-documented 24-h pattern of blood pressure with a morning surge that may contribute to the observed morning increase in adverse cardiovascular events. Historically, antihypertensive therapy involves morning doses, usually aimed at reducing daytime blood pressure surges, but an absence of nocturnal dipping blood pressure is also associated with increased cardiovascular risk. Recent Findings: To more effectively reduce nocturnal blood pressure and still counteract the morning surge in blood pressure, a number of studies have examined moving one or more antihypertensives from morning to bedtime dosing. More recently, such studies of chronotherapy have studied comorbid populations including obstructive sleep apnea, chronic kidney disease, or diabetes. Summary: Here, we summarize major findings from recent research in this area (2013–2017). In general, nighttime administration of antihypertensives improved overall 24-h blood pressure profiles regardless of disease comorbidity. However, inconsistencies between studies suggest a need for more prospective randomized controlled trials with sufficient statistical power. In addition, experimental studies to ascertain mechanisms by which chronotherapy is beneficial could aid drug design and guidelines for timed administration.",
keywords = "Blood pressure, Chronotherapy, Circadian rhythms, Hypertension, Non-dipping, Sleep",
author = "Bowles, {N. P.} and Thosar, {S. S.} and Herzig, {M. X.} and Steven Shea",
year = "2018",
month = "11",
day = "1",
doi = "10.1007/s11906-018-0897-4",
language = "English (US)",
volume = "20",
journal = "Current Hypertension Reports",
issn = "1522-6417",
publisher = "Current Medicine Group",
number = "11",

}

TY - JOUR

T1 - Chronotherapy for Hypertension

AU - Bowles, N. P.

AU - Thosar, S. S.

AU - Herzig, M. X.

AU - Shea, Steven

PY - 2018/11/1

Y1 - 2018/11/1

N2 - Purpose of Review: Given the emerging knowledge that circadian rhythmicity exists in every cell and all organ systems, there is increasing interest in the possible benefits of chronotherapy for many diseases. There is a well-documented 24-h pattern of blood pressure with a morning surge that may contribute to the observed morning increase in adverse cardiovascular events. Historically, antihypertensive therapy involves morning doses, usually aimed at reducing daytime blood pressure surges, but an absence of nocturnal dipping blood pressure is also associated with increased cardiovascular risk. Recent Findings: To more effectively reduce nocturnal blood pressure and still counteract the morning surge in blood pressure, a number of studies have examined moving one or more antihypertensives from morning to bedtime dosing. More recently, such studies of chronotherapy have studied comorbid populations including obstructive sleep apnea, chronic kidney disease, or diabetes. Summary: Here, we summarize major findings from recent research in this area (2013–2017). In general, nighttime administration of antihypertensives improved overall 24-h blood pressure profiles regardless of disease comorbidity. However, inconsistencies between studies suggest a need for more prospective randomized controlled trials with sufficient statistical power. In addition, experimental studies to ascertain mechanisms by which chronotherapy is beneficial could aid drug design and guidelines for timed administration.

AB - Purpose of Review: Given the emerging knowledge that circadian rhythmicity exists in every cell and all organ systems, there is increasing interest in the possible benefits of chronotherapy for many diseases. There is a well-documented 24-h pattern of blood pressure with a morning surge that may contribute to the observed morning increase in adverse cardiovascular events. Historically, antihypertensive therapy involves morning doses, usually aimed at reducing daytime blood pressure surges, but an absence of nocturnal dipping blood pressure is also associated with increased cardiovascular risk. Recent Findings: To more effectively reduce nocturnal blood pressure and still counteract the morning surge in blood pressure, a number of studies have examined moving one or more antihypertensives from morning to bedtime dosing. More recently, such studies of chronotherapy have studied comorbid populations including obstructive sleep apnea, chronic kidney disease, or diabetes. Summary: Here, we summarize major findings from recent research in this area (2013–2017). In general, nighttime administration of antihypertensives improved overall 24-h blood pressure profiles regardless of disease comorbidity. However, inconsistencies between studies suggest a need for more prospective randomized controlled trials with sufficient statistical power. In addition, experimental studies to ascertain mechanisms by which chronotherapy is beneficial could aid drug design and guidelines for timed administration.

KW - Blood pressure

KW - Chronotherapy

KW - Circadian rhythms

KW - Hypertension

KW - Non-dipping

KW - Sleep

UR - http://www.scopus.com/inward/record.url?scp=85054132333&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054132333&partnerID=8YFLogxK

U2 - 10.1007/s11906-018-0897-4

DO - 10.1007/s11906-018-0897-4

M3 - Review article

C2 - 30267334

AN - SCOPUS:85054132333

VL - 20

JO - Current Hypertension Reports

JF - Current Hypertension Reports

SN - 1522-6417

IS - 11

M1 - 97

ER -